Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_assertion type Assertion NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_head.
- NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_assertion description "[In the present study, we investigated the expression of DCC, P53 and HER-2/neu product in surgical specimens from 79 patients with invasive breast cancer by immunohistochemistry staining and found the expression of DCC to be decreased in 42 tumors (52%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_provenance.
- NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_assertion evidence source_evidence_literature NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_provenance.
- NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_assertion SIO_000772 10969518 NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_provenance.
- NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_assertion wasDerivedFrom befree-2016 NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_provenance.
- NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_assertion wasGeneratedBy ECO_0000203 NP293797.RAwqpTafmNaf5AaYLw_5iVJzdM0t--Xa9LvlD9Mdlj7yU130_provenance.